Related Experiment Video
Updated: Jun 5, 2026
04:30
Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models
Published on: March 8, 2024
Desaturation following rapid sequence induction using succinylcholine vs. rocuronium in overweight patients
1Department of Anesthesiology, Shanghai First People's Hospital, Shanghai Jiaotong University, China.
Acta Anaesthesiologica Scandinavica
|January 14, 2011
Summary
In overweight patients, succinylcholine caused faster oxygen desaturation during rapid sequence induction compared to rocuronium. Rocuronium also led to a quicker recovery of oxygen saturation.
Area of Science:
- Anesthesiology
- Critical Care Medicine
- Pharmacology
Background:
- Rapid sequence induction (RSI) is a critical anesthetic procedure.
- Overweight patients may be at higher risk for hypoxemia during RSI.
Purpose of the Study:
- To compare the effects of succinylcholine and rocuronium on oxygen desaturation during RSI in overweight patients.
Main Methods:
- Sixty overweight patients (BMI 25-30 kg/m²) were randomized to receive either succinylcholine or rocuronium for RSI.
- Ventilation was delayed until oxygen saturation (SpO2) reached 92% to measure Safe Apnea Time.
- Arterial blood gases were analyzed at multiple time points.
Main Results:
- Safe Apnea Time was significantly longer with rocuronium (329 s) compared to succinylcholine (283 s).
- Recovery period was significantly shorter with rocuronium (36 s) versus succinylcholine (43 s).
- No significant differences in blood gas analysis were observed between the groups.
Conclusions:
- Rocuronium offers a longer Safe Apnea Time and faster recovery of oxygen saturation than succinylcholine in overweight patients undergoing RSI.
- These findings suggest rocuronium may be a safer alternative for RSI in this patient population.
Related Concept Videos
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...